HTLV-I Foundation, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran.
Immunology Research Centre, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Iran J Basic Med Sci. 2013 Mar;16(3):264-7.
OBJECTIVE(S): The aim of this study was to investigate the association between HLA class I alleles (HLA-A02, HLA-A24, HLA-Cw*08, HLA-B5401) and proviral load in HTLV-I associated myelopathy/tropical spastic paraperesis (HAM/TSP) patients in Iranian population.
20 new cases of HAM/TSP patients and 30 HTLV-I infected healthy carriers were recruited. Peripheral blood samples were collected. Peripheral blood mononuclear cells (PBMCs) were isolated. DNA was extracted from PBMC.HTLV-I proviral load was calculated by Taqman quantitative real time polymerase chain reaction (qRT-PCR). PCR sequence-specific primer (PCR-SSP) reactions were performed to detect HLA-A, HLA-B and, HLA-Cw alleles.
There was no significant difference in sex and age between asymptomatic and HAM/TSP group. The Mann-Whitney U test was used to compare proviral load between HAM/TSP patients and healthy carrier. Provirus load of HAM/TSP patients was significantly higher than that of HCs (P=0.003, Mann-Whitney U test).Odd ratio was calculated to determine association between class I alleles including (HLA-A02, HLA-A24, HLA-Cw08) and risk of HAM/TSP development. We couldn't find any association between these class I alleles and risk of HAM/TSP development in our study. In our survey HLA-A02, HLA-A24, HLA-Cw*08 didn't have protective effect on proviral load (P=0.075, P=0.060 and 0.650 Mann-Whitney U test respectively).
In conclusion, certain HLA alleles with protective effect in one population may have not similar effect in other population. This may be because of pathogen polymorphism or host genetic heterogeneity and allele frequency in desired population.
本研究旨在探讨伊朗人群中 HLA I 类等位基因(HLA-A02、HLA-A24、HLA-Cw*08、HLA-B5401)与 HTLV-I 相关脊髓病/热带痉挛性截瘫(HAM/TSP)患者前病毒载量之间的关系。
招募了 20 例新的 HAM/TSP 患者和 30 例 HTLV-I 感染的健康携带者。采集外周血样本。分离外周血单核细胞(PBMC)。从 PBMC 中提取 DNA。采用 Taqman 实时定量聚合酶链反应(qRT-PCR)计算 HTLV-I 前病毒载量。进行聚合酶链反应序列特异性引物(PCR-SSP)反应以检测 HLA-A、HLA-B 和 HLA-Cw 等位基因。
无症状和 HAM/TSP 组在性别和年龄上无显著性差异。采用 Mann-Whitney U 检验比较 HAM/TSP 患者和健康携带者的前病毒载量。HAM/TSP 患者的前病毒载量明显高于 HC(P=0.003,Mann-Whitney U 检验)。计算比值比以确定包括(HLA-A02、HLA-A24、HLA-Cw08)在内的 I 类等位基因与 HAM/TSP 发展风险之间的关系。我们在本研究中没有发现这些 I 类等位基因与 HAM/TSP 发展风险之间的任何关联。在我们的调查中,HLA-A02、HLA-A24、HLA-Cw*08 对前病毒载量没有保护作用(P=0.075、P=0.060 和 0.650 曼-惠特尼 U 检验)。
总之,在一个人群中具有保护作用的某些 HLA 等位基因在其他人群中可能没有类似的作用。这可能是由于病原体多态性或宿主遗传异质性和目标人群中等位基因频率的不同。